Abstract:Background MRI is of increasing importance in the diagnostic evaluation of gastrointestinal diseases, with depiction of mucosal enhancement obtained with conventional intravenous contrast. Routine clinical use of contrast agents has been carried out using intravenous injection for mucosal imaging. Contrast agents that specifically target the intestinal mucosa are therefore needed to improve clinical imaging of the mucosal surface. Purpose To synthesize a novel contrast agent for gadopentetic acid (Gd-DTPA)-loaded chitosan nanoparticles and observe the absorption of the nanoparticles in the colon wall of healthy rats by MR imaging in vivo. Material and Methods A contrast agent was successfully synthesized by a modified emulsion coalescence method, and the resulting agents were characterized in detail by dynamic light-scattering spectroscopy and inductively coupled plasma emission spectroscopy. The cytotoxicity of Gd-chitosan nanoparticles was evaluated by an MTT assay. Gadolinium-chitosan (Gd@chitosan) nanoparticles were administered to the colon mucosa of healthy rats by rectal administration, and MRI scans in vivo were carried out with a 3.0 T imaging scanner at various time points. Results The prepared Gd@chitosan nanoparticles were ∼420 nm in diameter with a 74.4% Gd-DTPA content. The MTT assay indicated little cytotoxicity. MRI results showed that nanoparticles can be retained in both the stratum submucosum and epithelial cells of the colon for almost 80 min. Transmission electron microscopy images further revealed that Gd@chitosan nanoparticles were localized inside the mucosal cells or intercellular space, while tissue from Gd-DTPA aqueous solution administration showed nothing. Due to the infusion of Gd@chitosan nanoparticles, the MR signal intensity of colon mucosa increased from about 6% to 35%, and the contrast enhancement was highest at 20 min after administration. Conclusion Gd@chitosan nanoparticles with high Gd-DTPA content were successfully prepared for use as a novel MRI contrast agent. All results indicated that rectally administered Gd@chitosan nanoparticles have the potential for MRI diagnosis of colon mucosal disease.

A novel CT contrast agent for intestinal-targeted imaging through rectal administration

A Novel Magnetic Contrast Agent for Gastrointestinal Mucosa-Targeted Imaging Through Oral Administration.

Gadolinium-chitosan Nanoparticles As a Novel Contrast Agent for Potential Use in Clinical Bowel-Targeted MRI: a Feasibility Study in Healthy Rats.

Efficient Oral Delivery of Water-Soluble CT Contrast Agent Using an W1/O/W2 Alginate Hydrogel Matrix.

Gd-DTPA-chitosan Particles As a Magnetic Resonance Contrast Agent for Rat's Intestinal Mucosa Targeted Imaging

Cell membrane-functionalized bismuth oxyiodide nanodots as potential contrast agent for gastrointestinal tract imaging

Liposome-camouflaged iodinated mesoporous silica nanoparticles with high loading capacity, high hemodynamic stability, high biocompatibility and high radiopacity

Non-toxic lead sulfide nanodots as efficient contrast agents for visualizing gastrointestinal tract

Organic Nanoplatforms for Iodinated Contrast Media in CT Imaging

Bismuth drug-inspired ultra-small dextran coated bismuth oxide nanoparticles for targeted computed tomography imaging of inflammatory bowel disease

Self‐Assembled Nano‐Ct Contrast Agent Leveraging Size Aggregation for Improved in Vivo Tumor Ct Imaging

Bismuth chelate as a contrast agent for X-ray computed tomography

Direct Visualization of Gastrointestinal Tract with Lanthanide-Doped BaYbF5 Upconversion Nanoprobes

Synthesis and characterization of ethosomal contrast agents containing iodine for computed tomography (CT) imaging applications

Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Multi-Detector Ct Enterography with Iso-Osmotic Mannitol As Oral Contrast for Detecting Small Bowel Disease

Toward the Clinical Translation of Safe Intravenous Long Circulating Iodinated Lipid Nanoemulsion Contrast Agents for CT Imaging

Non-invasive Multimodal Functional Imaging of the Intestine with Frozen Micellar Naphthalocyanines.

Development of a Novel MR Colonography via Iron-Based Solid Lipid Nanoparticles

A novel food-based foam as oral contrast agent with negative Hounsfield units for demarcation of small bowel loops on abdominal CT: tolerability and bowel distension in 25 volunteers